Examination of behavioral deficits triggered by targeting BDNF in fetal or postnatal brains of mice

Neuroscience

Volumn 142, Issue 1, 2006, Pages 49-58

  Chan, J P ^a   Unger, T J ^a   Byrnes, J ^a   Rios, M ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

aggressive; anxiety; cre loxP; depression; mutant; neurotrophin

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; NEUROTROPHIN; SEROTONIN 2A RECEPTOR;

AGGRESSION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; BEHAVIOR CHANGE; BEHAVIOR DISORDER; BRAIN; BRAIN DEVELOPMENT; BRAIN LEVEL; CONTROLLED STUDY; DEPRESSION; FETUS (ANATOMY); FORCED SWIMMING TEST; FRONTAL CORTEX; HYPERACTIVITY; KNOCKOUT MOUSE; LIGHT DARK CYCLE; LOCOMOTION; MOOD; MOUSE; MOUSE MUTANT; NEUROMODULATION; NONHUMAN; PHENOTYPE; POSTNATAL DEVELOPMENT; PRENATAL PERIOD; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; SUSPENSION; TAIL;

AGGRESSION; ANIMALS; ANIMALS, NEWBORN; ANXIETY; BEHAVIOR, ANIMAL; BLOTTING, NORTHERN; BLOTTING, WESTERN; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSION; FEMALE; GENE EXPRESSION; HINDLIMB SUSPENSION; IMMUNOHISTOCHEMISTRY; MALE; MAZE LEARNING; MENTAL DISORDERS; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; PSYCHOMOTOR PERFORMANCE; REACTION TIME;

EID: 33748468922     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.06.002     Document Type: Article

References (54)

1. Altar C.A., Boylan C.B., Fritsche M., Jackson C., Hyman C., and Lindsay R.M. The neurotrophins NT-4/5 and BDNF augment serotonin, dopamine, and GABAergic systems during behaviorally effective infusions to the substantia nigra. Exp Neurol 130 (1994) 31-40
2. Altar C.A., Whitehead R.E., Chen R., Wortwein G., and Madsen T.M. Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain. Biol Psychiatry 54 (2003) 703-709
3. Bates B., Rios M., Trumpp A., Chen C., Fan G., Bishop J.M., and Jaenisch R. Neurotrophin-3 is required for proper cerebellar development. Nat Neurosci 2 (1999) 115-117
4. Chen B., Dowlatshahi D., MacQueen G.M., Wang J.F., and Young L.T. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 50 (2001) 260-265
5. Chourbaji S., Hellweg R., Brandis D., Zorner B., Zacher C., Lang U.E., Henn F.A., Hortnagl H., and Gass P. Mice with reduced brain-derived neurotrophic factor expression show decreased choline acetyltransferase activity, but regular brain monoamine levels and unaltered emotional behavior. Brain Res Mol Brain Res 121 (2004) 28-36
6. Cryan J.F., and Holmes A. The ascent of mouse: advances in modelling human depression and anxiety. Nat Rev Drug Discov 4 (2005) 775-790
7. Duman R.S. Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Med 5 (2004) 11-25
8. Dwivedi Y., Rizavi H.S., Roberts R.C., Conley R.C., Tamminga C.A., and Pandey G.N. Reduced activation and expression of ERK1/2 MAP kinase in the post- mortem brain of depressed suicide subjects. J Neurochem 77 (2001) 916-928
9. Ernfors P., Lee K.F., and Jaenisch R. Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature 368 (1994) 147-150
10. Gurevich I., Tamir H., Arango V., Dwork A.J., Mann J.J., and Schmauss C. Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims. Neuron 34 (2002) 349-356
11. Harrison P.J. The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology (Berl) 174 (2004) 151-162
12. Huntley G.W., Benson D.L., Jones E.G., and Isackson P.J. Developmental expression of brain derived neurotrophic factor mRNA by neurons of fetal and adult monkey prefrontal cortex. Brain Res Dev Brain Res 70 (1992) 53-63
13. Hwang J.P., Tsai S.J., Hong C.J., Yang C.H., Lirng J.F., and Yang Y.M. The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression. Neurobiol Aging (2005) [Epub ahead of print]. doi:10.1016/j.neurobiolaging.2005.10.013.
14. Jiang X., Xu K., Hoberman J., Tian F., Marko A.J., Waheed J.F., Harris C.R., Marini A.M., Enoch M.A., and Lipsky R.H. BDNF variation and mood disorders: a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects. Neuropsychopharmacology 30 (2005) 1353-1361
15. Jones K.R., Farinas I., Backus C., and Reichardt L.F. Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development. Cell 76 (1994) 989-999
16. Kalia M. Neurobiological basis of depression: an update. Metabolism 54 (2005) 24-27
17. Kernie S.G., Liebl D.J., and Parada L.F. BDNF regulates eating behavior and locomotor activity in mice. EMBO J 19 (2000) 1290-1300
18. Koponen E., Voikar V., Riekki R., Saarelainen T., Rauramaa T., Rauvala H., Taira T., and Castren E. Transgenic mice overexpressing the full-length neurotrophin receptor trkB exhibit increased activation of the trkB-PLCgamma pathway, reduced anxiety, and facilitated learning. Mol Cell Neurosci 26 (2004) 166-181
19. Lang U.E., Hellweg R., Kalus P., Bajbouj M., Lenzen K.P., Sander T., Kunz D., and Gallinat J. Association of a functional BDNF polymorphism and anxiety-related personality traits. Psychopharmacology (Berl) 180 (2005) 95-99
20. Lerer B., Macciardi F., Segman R.H., Adolfsson R., Blackwood D., Blairy S., Del Favero J., Dikeos D.G., Kaneva R., Lilli R., Massat I., Milanova V., Muir W., Noethen M., Oruc L., Petrova T., Papadimitriou G.N., Rietschel M., Serretti A., Souery D., Van Gestel S., Van Broeckhoven C., and Mendlewicz J. Variability of 5-HT2C receptor cys23ser polymorphism among European populations and vulnerability to affective disorder. Mol Psychiatry 6 (2001) 579-585
21. Lu B., and Figurov A. Role of neurotrophins in synapse development and plasticity. Rev Neurosci 8 (1997) 1-12
22. Lyons W.E., Mamounas L.A., Ricaurte G.A., Coppola V., Reid S.W., Bora S.H., Wihler C., Koliatsos V.E., and Tessarollo L. Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc Natl Acad Sci U S A 96 (1999) 15239-15244
23. MacQueen G.M., Ramakrishnan K., Croll S.D., Siuciak J.A., Yu G., Young L.T., and Fahnestock M. Performance of heterozygous brain-derived neurotrophic factor knockout mice on behavioral analogues of anxiety, nociception, and depression. Behav Neurosci 115 (2001) 1145-1153
24. Mamounas L.A., Altar C.A., Blue M.E., Kaplan D.R., Tessarollo L., and Lyons W.E. BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brain. J Neurosci 20 (2000) 771-782
25. Marmigere F., Rage F., Tapia-Arancibia L., and Arancibia S. Expression of mRNAs encoding BDNF and its receptor in adult rat hypothalamus. Neuroreport 9 (1998) 1159-1163
26. Masana Y., Wanaka A., Kato H., Asai T., and Tohyama M. Localization of trkB mRNA in postnatal brain development. J Neurosci Res 35 (1993) 468-479
27. Mitsukawa K., Mombereau C., Lotscher E., Uzunov D.P., van der Putten H., Flor P.J., and Cryan J.F. Metabotropic glutamate receptor subtype 7 ablation causes dysregulation of the HPA axis and increases hippocampal BDNF protein levels: implications for stress-related psychiatric disorders. Neuropsychopharmacology (2005) [Epub ahead of print]
28. Monteggia L.M., Barrot M., Powell C.M., Berton O., Galanis V., Gemelli T., Meuth S., Nagy A., Greene R.W., and Nestler E.J. Essential role of brain-derived neurotrophic factor in adult hippocampal function. Proc Natl Acad Sci U S A 101 (2004) 10827-10832
29. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., and Monteggia L.M. Neurobiology of depression. Neuron 34 (2002) 13-25
30. Neves-Pereira M., Mundo E., Muglia P., King N., Macciardi F., and Kennedy J.L. The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am J Hum Genet 71 (2002) 651-655
31. Nibuya M., Morinobu S., and Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15 (1995) 7539-7547
32. Nomura M., Kusumi I., Kaneko M., Masui T., Daiguji M., Ueno T., Koyama T., and Nomura Y. Involvement of a polymorphism in the 5-HT2A receptor gene in impulsive behavior. Psychopharmacology (2006) [Epub ahead of print]
33. Nonogaki K., Abdallah L., Goulding E.H., Bonasera S.J., and Tecott L.H. Hyperactivity and reduced energy cost of physical activity in serotonin 5-HT (2C) receptor mutant mice. Diabetes 52 (2003) 135-120
34. Numan S., and Seroogy K.B. Expression of trkB and trkC mRNAs by adult midbrain dopamine neurons: a double-label in situ hybridization study. J Comp Neurol 403 (1999) 295-308
35. Porsolt R.D., Bertin A., and Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229 (1977) 327-336
36. Renard C.E., Dailly E., David D.J., Hascoet M., and Bourin M. Monoamine metabolism changes following the mouse forced swimming test but not the tail suspension test. Fundam Clin Pharmacol 17 (2003) 449-455
37. Ridder S., Chourbaji S., Hellweg R., Urani A., Zacher C., Schmid W., Zink M., Hortnagl H., Flor H., Henn F.A., Schutz G., and Gass P. Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions. J Neurosci 25 (2005) 6243-6250
38. Rios M., Fan G., Fekete C., Kelly J., Bates B., Kuehn R., Lechan R.M., and Jaenisch R. Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol Endocrinol 15 (2001) 1748-1757
39. Rios M., Lambe E.K., Liu R., Teillon S., Liu J., Akbarian S., Roffler-Tarlov S., Jaenisch R., and Aghajanian G.K. Severe deficits in 5-HT(2A)-mediated neurotransmission in BDNF conditional mutant mice. J Neurobiol 66 (2006) 408-420
40. Saarelainen T., Hendolin P., Lucas G., Koponen E., Sairanen M.M., MacDonald E., Agerman K., Haapasalo A., Nawa H., Aloyz R., Ernfors P., and Castren E. Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J Neurosci 23 (2003) 349-357
41. Sanchez C. Acute stress enhances anxiolytic-like drug responses of mice tested in a black and white test box. Eur Neuropsychopharmacol 7 (1997) 283-288
42. Saudou F., Amara D.A., Dierich A., LeMeur M., Ramboz S., Segu L., Buhot M.C., and Hen R. Enhanced aggressive behavior in mice lacking 5-HT1B receptor. Science 265 (1994) 1875-1878
43. Shen L., Figurov A., and Lu B. Recent progress in studies of neurotrophic factors and their clinical implications. J Mol Med 75 (1997) 637-644
44. Shirayama Y., Chen A.C., Nakagawa S., Russell D.S., and Duman R.S. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 22 (2002) 3251-3261
45. Siuciak J.A., Lewis D.R., Wiegand S.J., and Lindsay R.M. Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol Biochem Behav 56 (1997) 131-137
46. Siuciak J.A., Clark M.S., Rind H.B., Whittemore S.R., and Russo A.F. BDNF induction of tryptophan hydroxylase mRNA levels in the rat brain. J Neurosci Res 52 (1998) 149-158
47. Sklar P., Gabriel S.B., McInnis M.G., Bennett P., Lim Y.M., Tsan G., Schaffner S., Kirov G., Jones I., Owen M., Craddock N., DePaulo J.R., and Lander E.S. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Mol Psychiatry 7 (2002) 579-593
48. Smith M.A., Makino S., Kvetnansky R., and Post R.M. Effects of stress on neurotrophic factor expression in the rat brain. Ann N Y Acad Sci 771 (1995) 234-239
49. Soares J.C., and Mann J.J. The anatomy of mood disorders: review of structural neuroimaging studies. Biol Psychiatry 41 (1997) 86-106
50. Steru L., Chermat R., Thierry B., and Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 85 (1985) 367-370
51. Strekalova T., Spanagel R., Dolgov O., and Bartsch D. Stress-induced hyperlocomotion as a confounding factor in anxiety and depression models in mice. Behav Pharmacol 16 (2005) 171-180
52. Trumpp A., Depew M.J., Rubenstein J.L., Bishop J.M., and Martin G.R. Cre-mediated gene inactivation demonstrates that FGF8 is required for cell survival and patterning of the first branchial arch. Genes Dev 13 (1999) 3136-3148
53. van Gaalen M.M., and Steckler T. Behavioural analysis of four mouse strains in an anxiety test battery. Behav Brain Res 115 (2000) 95-106
54. Zorner B., Wolfer D.P., Brandis D., Kretz O., Zacher C., Madani R., Grunwald I., Lipp H.P., Klein R., Henn F.A., and Gass P. Forebrain-specific trkB-receptor knockout mice: behaviorally more hyperactive than "depressive.". Biol Psychiatry 54 (2003) 972-982